PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedicine, Aarhus University, Aarhus, Denmark.\', \'Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.\', \'Olink Proteomics, Uppsala, Sweden.\', \'Randers Regional Hospital, Randers, Denmark.\', \'Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.\', \'Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.\', \'Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.\', \'Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.\', \'Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.\', \'Department of Emergency Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.\', \'The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.\', \'Centre for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.\', \'Department of Biostatistics, Aarhus University, Aarhus, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0252799
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34086837
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all